
Samantha L. Shterengarts
Examiner (ID: 8624, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1623, 4131 |
| Total Applications | 2403 |
| Issued Applications | 1806 |
| Pending Applications | 134 |
| Abandoned Applications | 481 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16970397
[patent_doc_number] => 11066357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Benzoannulene derivatives as antiviral agents
[patent_app_type] => utility
[patent_app_number] => 16/954464
[patent_app_country] => US
[patent_app_date] => 2018-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 361
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954464
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/954464 | Benzoannulene derivatives as antiviral agents | Dec 23, 2018 | Issued |
Array
(
[id] => 15264555
[patent_doc_number] => 20190381011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => CARBOXAMIDE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/230033
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16230033
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/230033 | CARBOXAMIDE DERIVATIVES | Dec 20, 2018 | Abandoned |
Array
(
[id] => 16398733
[patent_doc_number] => 20200339591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA
[patent_app_type] => utility
[patent_app_number] => 16/955811
[patent_app_country] => US
[patent_app_date] => 2018-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955811 | COMPOSITIONS AND METHODS OF TREATMENT FOR NEUROLOGICAL DISORDERS COMPRISING A DEMENTIA | Dec 19, 2018 | Abandoned |
Array
(
[id] => 17815360
[patent_doc_number] => 11420958
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Aryl and heteroaryl substituted indole compounds
[patent_app_type] => utility
[patent_app_number] => 16/955314
[patent_app_country] => US
[patent_app_date] => 2018-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19198
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955314 | Aryl and heteroaryl substituted indole compounds | Dec 18, 2018 | Issued |
Array
(
[id] => 17193089
[patent_doc_number] => 11161829
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-11-02
[patent_title] => Dihydrofuran chalcone compound and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 16/626943
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2287
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626943 | Dihydrofuran chalcone compound and preparation method thereof | Dec 17, 2018 | Issued |
Array
(
[id] => 14501071
[patent_doc_number] => 20190194190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => Compounds and Their Use in Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 16/223224
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120258
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223224 | Compounds and their use in treating cancer | Dec 17, 2018 | Issued |
Array
(
[id] => 15784799
[patent_doc_number] => 10626106
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => Substituted pyrrolidine amides I
[patent_app_type] => utility
[patent_app_number] => 16/223845
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26285
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 473
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16223845
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/223845 | Substituted pyrrolidine amides I | Dec 17, 2018 | Issued |
Array
(
[id] => 15177973
[patent_doc_number] => 20190359578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/220254
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220254 | TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME | Dec 13, 2018 | Abandoned |
Array
(
[id] => 14213741
[patent_doc_number] => 20190119255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => GLP-1 Receptor Agonists and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/220184
[patent_app_country] => US
[patent_app_date] => 2018-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16220184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/220184 | GLP-1 receptor agonists and uses thereof | Dec 13, 2018 | Issued |
Array
(
[id] => 17363527
[patent_doc_number] => 11230542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Inhibitors of integrated stress response pathway
[patent_app_type] => utility
[patent_app_number] => 16/219805
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 45
[patent_no_of_words] => 97358
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/219805 | Inhibitors of integrated stress response pathway | Dec 12, 2018 | Issued |
Array
(
[id] => 16824214
[patent_doc_number] => 20210139507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => FUSED PYRIDINES WHICH ACT AS INHIBITORS OF H PGDS
[patent_app_type] => utility
[patent_app_number] => 16/771745
[patent_app_country] => US
[patent_app_date] => 2018-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 413
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771745 | FUSED PYRIDINES WHICH ACT AS INHIBITORS OF H PGDS | Dec 11, 2018 | Abandoned |
Array
(
[id] => 16261227
[patent_doc_number] => 10752646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Method of making phosphono-phosphate containing compounds
[patent_app_type] => utility
[patent_app_number] => 16/215704
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14312
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16215704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/215704 | Method of making phosphono-phosphate containing compounds | Dec 10, 2018 | Issued |
Array
(
[id] => 17452963
[patent_doc_number] => 11267808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Benzamide derivatives as PPAR-gamma modulators
[patent_app_type] => utility
[patent_app_number] => 16/771514
[patent_app_country] => US
[patent_app_date] => 2018-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10135
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771514 | Benzamide derivatives as PPAR-gamma modulators | Dec 10, 2018 | Issued |
Array
(
[id] => 14156415
[patent_doc_number] => 20190105310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => PHARMACEUTICAL FORMULATIONS COMPRISING A PYRIDYLAMINOACETIC ACID COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/211839
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16211839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/211839 | Pharmaceutical formulations comprising a pyridylaminoacetic acid compound | Dec 5, 2018 | Issued |
Array
(
[id] => 14132305
[patent_doc_number] => 20190100542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => CRYSTAL FORM OF TENOFOVIR ALAFENAMIDE SALT, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/208721
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16208721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/208721 | Crystal form of tenofovir alafenamide salt, preparation method and use thereof | Dec 3, 2018 | Issued |
Array
(
[id] => 16328276
[patent_doc_number] => 20200299242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => PROCESS FOR THE PREPARATION OF ROXADUSTAT AND ITS INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 16/768523
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768523
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768523 | PROCESS FOR THE PREPARATION OF ROXADUSTAT AND ITS INTERMEDIATES | Nov 29, 2018 | Abandoned |
Array
(
[id] => 17634963
[patent_doc_number] => 11345675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Compound, anti-allergy drug, and mediator release inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/057344
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7975
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057344 | Compound, anti-allergy drug, and mediator release inhibitor | Nov 29, 2018 | Issued |
Array
(
[id] => 16915671
[patent_doc_number] => 20210188763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/767919
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767919 | COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION | Nov 28, 2018 | Abandoned |
Array
(
[id] => 17881248
[patent_doc_number] => 20220296725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/766914
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766914 | Pyrrolobenzodiazepine antibody conjugates | Nov 26, 2018 | Issued |
Array
(
[id] => 18012072
[patent_doc_number] => 11504346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Redox-activated pro-chelators
[patent_app_type] => utility
[patent_app_number] => 16/200286
[patent_app_country] => US
[patent_app_date] => 2018-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5298
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16200286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/200286 | Redox-activated pro-chelators | Nov 25, 2018 | Issued |